Listed Launchpad SKU
On the Launchpad contract
Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo. This page does not start care.
Weight optimization · Launchpad care path
Semaglutide — a compounded GLP-1 on the partner care path.
The partner Launchpad catalog includes compounded semaglutide in the macro GLP-1s bucket, alongside tirzepatide. When care goes live, intake is hosted by our clinical partner: their licensed clinicians review, and their licensed 503A pharmacy network fills a patient-specific prescription if appropriate. Compounded semaglutide is not an FDA-approved branded product and is not a generic equivalent of Wegovy or Ozempic. This page is coming soon — not live care, enrollment, or a prescription today.
At a glance
What this page is built to clarify.
Listed Launchpad SKU
Partner clinicians decide
Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo. This page does not start care.
Listed Launchpad SKU
Not a branded-drug substitute
Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo. This page does not start care.
Clinical context
How to read this page.
These pages describe possible pathways, not a promise that any medication will be prescribed, shipped this week, or available in any state today. Livozo does not employ the prescriber. After Launchpad go-live, the clinical target is 50-state coverage via licensed partner clinicians. Louisiana blocks shipping of compounded GLP-1s.
Compounded semaglutide is not FDA-approved and is not a generic equivalent of Wegovy or Ozempic. Livozo does not prescribe. A partner clinician must review history and clinical need. This page is a care-path listing, not a promise that medication will be prescribed or shipped.
- Weight-optimization goals a clinician may review
- Metabolic context discussed with a partner clinician
- Interest in semaglutide under medical review
Partner model
What the partner path can include later.
When Launchpad is wired
- When care is live: Livozo marketing handoff, then partner intake
- Review by licensed partner clinicians
- Patient-specific 503A compounding through their pharmacy network when appropriate
- Partner-hosted portal, shipping, and support — not a Livozo clinic
Potential options
- Compounded semaglutide when a clinician documents need
- Not interchangeable with FDA-approved branded GLP-1s
- Tirzepatide is a separate Launchpad product page in the same contract bucket
Exact medication, formulation, quantity, refill timing, and pharmacy routing depend on the clinical partner, applicable law, and clinical appropriateness. The partner's licensed 503A pharmacy network — not an exclusive Red Rock claim — fulfills partner prescriptions if written. None of that is live today.
Next step
Coming soon — not a live clinic, enrollment, or prescription.
This is a Launchpad catalog listing under a coming-soon posture, not live clinician care. When Launchpad is wired, a marketing CTA will hand off to partner intake. Until then there is no enrollment, start-visit, or checkout path. No prescription, charge, or shipment happens from this site.
Also in this catalog